Method and apparatus for detection, identification and quantification of single-and multi-analytes in affinity-based sensor arrays
US-9223929-B2 · Dec 29, 2015 · US
US10106839B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10106839-B2 |
| Application number | US-201313854857-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 1, 2013 |
| Priority date | Aug 24, 2006 |
| Publication date | Oct 23, 2018 |
| Grant date | Oct 23, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A biosensor array, system and method for affinity based assays that are able to simultaneously obtain high quality measurements of the binding characteristics of multiple analytes, and that are able to determine the amounts of those analytes in solution. The invention also provides a fully integrated bioarray for detecting real-time characteristics of affinity based assays.
Opening claim text (preview).
What is claimed is: 1. A method comprising: (a) contacting a fluid containing a target analyte with a fully integrated biosensor array comprising: (i) a solid substrate comprising an array of semiconductor-based optical sensors; (ii) an optical filter layer integrated on top of the solid substrate; and (iii) a molecular recognition layer in contact with the optical filter layer and comprising probes that are immobilized to a surface of the molecular recognition layer at different non-contiguous spots corresponding to discrete and independently addressable locations; (b) illuminating the biosensor array; (c) detecting a decrease in fluorescence on the biosensor array by measuring fluorescence signals at multiple time points in real time while the fluid is in contact with the solid substrate; and (d) correlating the detected decrease in fluorescence measured at multiple time points with binding of the target analyte with a given one of the probes as a function of time, wherein (a)-(c) are performed without washing the fluid when in contact with the solid substrate, wherein the probes are coupled to fluorophores and the target analyte is coupled to a quencher, and wherein the detected decrease in fluorescence is upon a non-competitive assay of the target analyte and the given one of the probes. 2. The method of claim 1 , wherein the fluid comprises a plurality of different analytes including the target analyte, and wherein the probes are capable of specifically binding to the analytes. 3. The method of claim 2 further comprising the step of: using the signals measured at multiple time points to determine an original concentration of the target analyte in the fluid by analyzing a binding rate. 4. The method of claim 2 wherein a change in the signals with time correlates with a change in amounts of the analytes bound to the probes with time. 5. The method of claim 1 , further comprising the steps of: performing a nucleic acid amplification on two or more nucleotide sequences to produce two or more amplicons as analytes in the fluid in contact with the biosensor array, which analytes include the target analyte; and measuring the hybridization of the amplicons to two or more probes among the probes included in the molecular recognition layer while the fluid is in contact with the biosensor array to obtain an amplicon hybridization measurement. 6. The method of claim 5 further comprising using the amplicon hybridization measurement to determine a concentration of each of the nucleotide sequences in the fluid. 7. The method of claim 5 further comprising using the amplicon hybridization measurement to determine an original amount of each of the nucleotide sequences in the fluid. 8. The method of claim 1 , wherein the fully integrated biosensor array further comprises: an optical coupling layer integrated on top of the solid substrate and sandwiched between the molecular recognition layer and the semiconductor-based optical sensors. 9. The method of claim 4 , wherein the target analyte and probes are nucleic acids. 10. The method of claim 4 , wherein the target analyte and probes are polypeptides. 11. The method of claim 1 , wherein the biosensor array is illuminated from below the molecular recognition layer. 12. The method of claim 1 , wherein the molecular recognition layer comprises a control region which does not contain probes, and wherein the correlating in (d) comprises correcting for non-specific binding using signals from the control region. 13. The method of claim 1 , wherein the target analyte and probes are nucleic acids. 14. The method of claim 1 , wherein the target analyte and probes are polypeptides. 15. The method of claim 1 , wherein each of the discrete and independently addressable locations is configured to receive an excitation photon flux from a source located on a side of the molecular recognition layer. 16. The method of claim 8 , wherein the optical coupling layer further comprises a fiber-optic faceplate comprising packed optical fibers.
Electricity · mapped topic
using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title
involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings · CPC title
Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title
using an integrated detector array · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.